Follow
Carle Paul
Carle Paul
Université Toulouse 3 Paul Sabatier
Verified email at chu-toulouse.fr
Title
Cited by
Cited by
Year
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
CEM Griffiths, K Reich, M Lebwohl, P Van De Kerkhof, C Paul, A Menter, ...
The Lancet 386 (9993), 541-551, 2015
8842015
Phase 3 studies comparing brodalumab with ustekinumab in psoriasis
M Lebwohl, B Strober, A Menter, K Gordon, J Weglowska, L Puig, K Papp, ...
New England Journal of Medicine 373 (14), 1318-1328, 2015
8492015
Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
MG Lebwohl, H Bachelez, J Barker, G Girolomoni, A Kavanaugh, ...
Journal of the American Academy of Dermatology 70 (5), 871-881. e30, 2014
5792014
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open …
P Joly, M Maho-Vaillant, C Prost-Squarcioni, V Hebert, E Houivet, S Calbo, ...
The Lancet 389 (10083), 2031-2040, 2017
557*2017
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study
COVIDSurg Collaborative
Anaesthesia 76 (6), 748-758, 2021
554*2021
European S3‐Guidelines on the systemic treatment of psoriasis vulgaris–Update 2015–Short version–EDF in cooperation with EADV and IPC
A Nast, P Gisondi, AD Ormerod, P Saiag, C Smith, PI Spuls, P Arenberger, ...
Journal of the European Academy of Dermatology and Venereology 29 (12), 2277 …, 2015
5432015
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children
U Wahn, JD Bos, M Goodfield, R Caputo, K Papp, A Manjra, A Dobozy, ...
Pediatrics 110 (1), e2-e2, 2002
5272002
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled …
C Paul, J Cather, M Gooderham, Y Poulin, U Mrowietz, C Ferrandiz, ...
British Journal of Dermatology 173 (6), 1387-1399, 2015
4942015
Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study
CF Paul, VC Ho, C McGeown, E Christophers, B Schmidtmann, ...
Journal of Investigative Dermatology 120 (2), 211-216, 2003
4792003
A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis
KA Papp, K Reich, C Paul, A Blauvelt, W Baran, C Bolduc, D Toth, ...
British Journal of Dermatology 175 (2), 273-286, 2016
4782016
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug
A Kapp, K Papp, A Bingham, R Fölster-Holst, JP Ortonne, PC Potter, ...
Journal of Allergy and Clinical Immunology 110 (2), 277-284, 2002
418*2002
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review
C Horreau, C Pouplard, E Brenaut, T Barnetche, L Misery, B Cribier, ...
Journal of the European Academy of Dermatology and Venereology 27, 12-29, 2013
3962013
Carcinogenic risks of psoralen UV‐A therapy and narrowband UV‐B therapy in chronic plaque psoriasis: a systematic literature review
E Archier, S Devaux, E Castela, A Gallini, F Aubin, M Le Maître, ...
Journal of the European Academy of Dermatology and Venereology 26, 22-31, 2012
3832012
Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis
C Paul, P Wolkenstein, H Adle, J Wechsler, HJ Garchon, J Revuz, ...
British Journal of Dermatology 134 (4), 710-714, 1996
3821996
Secukinumab induction and maintenance therapy in moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled, phase II regimen‐finding study
P Rich, B Sigurgeirsson, D Thaci, JP Ortonne, C Paul, RE Schopf, ...
British Journal of Dermatology 168 (2), 402-411, 2013
3812013
Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis
FM Arellano, CE Wentworth, A Arana, C Fernández, CF Paul
Journal of Investigative dermatology 127 (4), 808-816, 2007
3582007
Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis
AP Villani, M Rouzaud, M Sevrain, T Barnetche, C Paul, MA Richard, ...
Journal of the American Academy of Dermatology 73 (2), 242-248, 2015
3512015
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
A Wollenberg, S Christen‐Zäch, A Taieb, C Paul, JP Thyssen, ...
Journal of the European Academy of Dermatology and Venereology 34 (12), 2717 …, 2020
3372020
Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE)
C Paul, JP Lacour, L Tedremets, K Kreutzer, S Jazayeri, S Adams, ...
Journal of the European Academy of Dermatology and Venereology 29 (6), 1082-1090, 2015
3352015
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature
E Puzenat, V Bronsard, S Prey, PA Gourraud, S Aractingi, M Bagot, ...
Journal of the European Academy of Dermatology and Venereology 24, 10-16, 2010
3272010
The system can't perform the operation now. Try again later.
Articles 1–20